REDWOOD CITY, Calif.,
Aug. 23, 2019 /PRNewswire/
-- Nevro Corp. (NYSE: NVRO), a global medical device
company that is providing innovative, evidence-based solutions for
the treatment of chronic pain, today announced the Company will be
participating in the Morgan Stanley 17th Annual
Healthcare Conference in New York
City. Nevro Chairman, CEO and President D. Keith Grossman is scheduled to present on
Monday, September 9, 2019 at
2:50 pm Eastern Time.
A live webcast of the presentation, as well as an archived
recording, will be available on the "Investors" section of the
Company's website at www.nevro.com.
About Nevro Corp.
Headquartered in Redwood City,
California, Nevro is a global medical device company focused
on providing innovative products that improve the quality of life
of patients suffering from debilitating chronic pain. Nevro has
developed and commercialized the Senza spinal cord stimulation
(SCS) system, an evidence-based, non-pharmacologic neuromodulation
platform for the treatment of chronic pain. The Senza® System and
Senza II™ System are the only SCS systems that deliver Nevro's
proprietary HF10® therapy. Senza, Senza II, HF10, Nevro and the
Nevro logo are trademarks of Nevro Corp.
Investor Relations
Juliet
Cunningham
Vice President, Investor Relations
650-433-3247
ir@nevro.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/nevro-to-present-at-morgan-stanley-17th-annual-healthcare-conference-300906236.html
SOURCE Nevro Corp.